Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Ford

Showing results (191-200 of 508) with videos related to

Pageof 51
Sort By:
Circulation|September 21, 2011
Intrathoracic impedance monitoring, audible patient alerts, and outcome in patients with heart failureDirk J van Veldhuisen, Frieder Braunschweig, Viviane Conraads, et al.
Lancet (London, England)|May 28, 2011
Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trialMarie-Germaine Bousser, Pierre Amarenco, Angel Chamorro, et al.
European Journal of Preventive Cardiology|September 28, 2019
Relationship between physical activity and long-term outcomes in patients with stable coronary artery diseaseSimone Biscaglia, Gianluca Campo, Emmanuel Sorbets, et al.
Journal of Lipid Research|January 10, 2013
PCSK9 SNP rs11591147 is associated with low cholesterol levels but not with cognitive performance or noncardiovascular clinical events in an elderly populationIris Postmus, Stella Trompet, Anton J M de Craen, et al.
European Heart Journal|December 28, 2018
β-blockers, calcium antagonists, and mortality in stable coronary artery disease: an international cohort studyEmmanuel Sorbets, Philippe Gabriel Steg, Robin Young, et al.
BMJ Open|December 20, 2013
Rationale and design of the PRognostic Importance of MIcrovascular Dysfunction in asymptomatic patients with Aortic Stenosis (PRIMID-AS): a multicentre observational study with blinded investigationsAnvesha Singh, Ian Ford, John P Greenwood, et al.
European Journal of Heart Failure|August 22, 2008
Can monitoring of intrathoracic impedance reduce morbidity and mortality in patients with chronic heart failure? Rationale and design of the Diagnostic Outcome Trial in Heart Failure (DOT-HF)Frieder Braunschweig, Ian Ford, Viviane Conraads, et al.
JAMA Internal Medicine|August 12, 2014
Prevalence of anginal symptoms and myocardial ischemia and their effect on clinical outcomes in outpatients with stable coronary artery disease: data from the International Observational CLARIFY RegistryPhilippe Gabriel Steg, Nicola Greenlaw, Michal Tendera, et al.
BMC Public Health|April 23, 2008
Psychological, social and biological determinants of ill health (pSoBid): study protocol of a population-based studyYoga N Velupillai, Chris J Packard, G David Batty, et al.
Polish Archives of Internal Medicine|February 23, 2017
Differences in outcomes in patients with stable coronary artery disease managed by cardiologists versus noncardiologists. Results from the international prospective CLARIFY registryZofia Parma, Philippe G Steg, Nicola Greenlaw, et al.
Pageof 51

Showing results (191-200 of 508) with videos related to

Sort By:
Pageof 51
Circulation|September 21, 2011
Intrathoracic impedance monitoring, audible patient alerts, and outcome in patients with heart failureDirk J van Veldhuisen, Frieder Braunschweig, Viviane Conraads, et al.
Lancet (London, England)|May 28, 2011
Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trialMarie-Germaine Bousser, Pierre Amarenco, Angel Chamorro, et al.
European Journal of Preventive Cardiology|September 28, 2019
Relationship between physical activity and long-term outcomes in patients with stable coronary artery diseaseSimone Biscaglia, Gianluca Campo, Emmanuel Sorbets, et al.
Journal of Lipid Research|January 10, 2013
PCSK9 SNP rs11591147 is associated with low cholesterol levels but not with cognitive performance or noncardiovascular clinical events in an elderly populationIris Postmus, Stella Trompet, Anton J M de Craen, et al.
European Heart Journal|December 28, 2018
β-blockers, calcium antagonists, and mortality in stable coronary artery disease: an international cohort studyEmmanuel Sorbets, Philippe Gabriel Steg, Robin Young, et al.
BMJ Open|December 20, 2013
Rationale and design of the PRognostic Importance of MIcrovascular Dysfunction in asymptomatic patients with Aortic Stenosis (PRIMID-AS): a multicentre observational study with blinded investigationsAnvesha Singh, Ian Ford, John P Greenwood, et al.
European Journal of Heart Failure|August 22, 2008
Can monitoring of intrathoracic impedance reduce morbidity and mortality in patients with chronic heart failure? Rationale and design of the Diagnostic Outcome Trial in Heart Failure (DOT-HF)Frieder Braunschweig, Ian Ford, Viviane Conraads, et al.
JAMA Internal Medicine|August 12, 2014
Prevalence of anginal symptoms and myocardial ischemia and their effect on clinical outcomes in outpatients with stable coronary artery disease: data from the International Observational CLARIFY RegistryPhilippe Gabriel Steg, Nicola Greenlaw, Michal Tendera, et al.
BMC Public Health|April 23, 2008
Psychological, social and biological determinants of ill health (pSoBid): study protocol of a population-based studyYoga N Velupillai, Chris J Packard, G David Batty, et al.
Polish Archives of Internal Medicine|February 23, 2017
Differences in outcomes in patients with stable coronary artery disease managed by cardiologists versus noncardiologists. Results from the international prospective CLARIFY registryZofia Parma, Philippe G Steg, Nicola Greenlaw, et al.
Pageof 51